Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 47.65
-0.50 (-1.04%)
At close: May 7, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.73 billion as of May 8, 2026. Its market cap has decreased by -1.59% in one year.
Market Cap
2.73B
Enterprise Value
2.34B
Revenue
222.03M
Ranking
n/a
PE Ratio
103.70
Stock Price
47.65
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.73B, an increase of 96.10%. That is a compound annual growth rate of 45.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.73B | -23.84% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 17.55B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.47B |
| Uwell Biopharma | 8.20B |
| Intelligene | 7.40B |
| Obigen Pharma | 3.99B |
| BIONET Therapeutics | 2.81B |
| Genomics BioSci & Tech. | 2.13B |
| FullHope Biomedical | 1.12B |